A nurse is preparing to administer methylergonovine IM for a client who had a vaginal delivery earlier that day. The nurse should explain to the client that this medication will help prevent which of the following? (Select onE.:

A. "You are far enough along that your baby will be just finE." This is not a good response because it is dismissive of the client's concerns and does not provide any factual information or reassurancE. The nurse should not make false promises or minimize the client's feelings.

B. "Everyone worries about their baby while they are in labor." This is not a good response because it is generalizing and does not address the client's specific situation. The nurse should not compare the client to others or imply that their worries are normal or insignificant.

D. "We have a neonatal unit here equipped to handle emergencies." This is not a good response because it implies that there is a high risk of complications and may increase the client's anxiety. The nurse should not focus on negative outcomes or scare the client with unnecessary information.

Choice A: The purpose of this medication is to stop preterm labor contractions is not a correct statement, as betamethasone is not a tocolytic agent that inhibits uterine activity. Betamethasone is a corticosteroid that enhances the production of surfactant and reduces the risk of respiratory distress syndrome in preterm infants.

Choice B: The purpose of this medication is to increase the fetal heart rate is not a correct statement, as betamethasone does not have a direct effect on the fetal heart ratE. Betamethasone may cause maternal tachycardia as a side effect, but it does not affect the fetal cardiac function.

Choice C: The purpose of this medication is to halt cervical dilation is not a correct statement, as betamethasone does not have an effect on the cervical ripening or effacement. Betamethasone is given to improve the fetal outcomes in case of preterm delivery, but it does not prevent or delay the labor process.

Choice D: The purpose of this medication is to boost fetal lung maturity is a correct statement, as betamethasone is a corticosteroid that stimulates the synthesis of surfactant and accelerates the maturation of the fetal lungs. Betamethasone is given to reduce the incidence and severity of respiratory distress syndrome and other neonatal complications in preterm infants.